HVD and NTI [Design Issues]

posted by dhavalpanchal – India, 2010-04-12 13:37 (5918 d 20:41 ago) – Posting: # 5085
Views: 4,114

Dear Members,

We are working on a molecule which shows high intrasubject variability (around 85% for Cmax) and having Narrow Therapeutic Index.

What can be the ideal study design to establish bioequivalence on the same ?

regards,

Dhaval

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
406 visitors (0 registered, 406 guests [including 27 identified bots]).
Forum time: 10:18 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5